Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons

Xi F. Gu, Efrain Azmitia

Research output: Contribution to journalArticle

Abstract

The direct effects of 3,4-methylenedioxymethamphetamine (MDMA) and p-chloroamphetamine (PCA) were studied in microculture of fetal 5-hydroxytryptamine (5-HT) neurons. Both MDMA and PCA released 5-HT with the potency of PCA > MDMA by a mechanism inhibited by fluoxetine, an inhibitor of the 5-HT transporter. The transporter-mediated release by MDMA and PCA reduced intracellular stores of 5-HT. Both MDMA and PCA inhibit MAO-A activities, which also contributes to the increase of extracellular 5-HT levels. Deprenyl (10-7 M) increased the amount of intracellular 5-HT and potentiated the MDMA- or PCA-induced release of 5-HT. Conversely, reserpine (10-9 M) reduced the intracellular 5-HT level and attenuated the transporter-mediated release. In addition, MDMA- or PCA-mediated release was attenuated by nimodipine (10-8 M), an L-type Ca2+ channel antagonist. Our results indicate that MDMA- or PCA-induced release of 5-HT occurs from the cytoplasm to the media through the 5-HT transporter, and that the release may incorporate 5-HT from the vesicular stores.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalEuropean Journal of Pharmacology
Volume235
Issue number1
DOIs
StatePublished - Apr 22 1993

Fingerprint

p-Chloroamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
Serotonin
Neurons
Selegiline
Nimodipine
Fluoxetine
Reserpine
Monoamine Oxidase
Cytoplasm

Keywords

  • Clorgyline
  • Deprenyl
  • Fluoxetine
  • MDMA (3,4-methylenedioxymethamphetamine)
  • Nimodipine
  • Parachloroamphetamine
  • Reserpine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

@article{22ec536aabdf45e7a408b8dc0b4a7f0f,
title = "Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons",
abstract = "The direct effects of 3,4-methylenedioxymethamphetamine (MDMA) and p-chloroamphetamine (PCA) were studied in microculture of fetal 5-hydroxytryptamine (5-HT) neurons. Both MDMA and PCA released 5-HT with the potency of PCA > MDMA by a mechanism inhibited by fluoxetine, an inhibitor of the 5-HT transporter. The transporter-mediated release by MDMA and PCA reduced intracellular stores of 5-HT. Both MDMA and PCA inhibit MAO-A activities, which also contributes to the increase of extracellular 5-HT levels. Deprenyl (10-7 M) increased the amount of intracellular 5-HT and potentiated the MDMA- or PCA-induced release of 5-HT. Conversely, reserpine (10-9 M) reduced the intracellular 5-HT level and attenuated the transporter-mediated release. In addition, MDMA- or PCA-mediated release was attenuated by nimodipine (10-8 M), an L-type Ca2+ channel antagonist. Our results indicate that MDMA- or PCA-induced release of 5-HT occurs from the cytoplasm to the media through the 5-HT transporter, and that the release may incorporate 5-HT from the vesicular stores.",
keywords = "Clorgyline, Deprenyl, Fluoxetine, MDMA (3,4-methylenedioxymethamphetamine), Nimodipine, Parachloroamphetamine, Reserpine",
author = "Gu, {Xi F.} and Efrain Azmitia",
year = "1993",
month = "4",
day = "22",
doi = "10.1016/0014-2999(93)90819-4",
language = "English (US)",
volume = "235",
pages = "51--57",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons

AU - Gu, Xi F.

AU - Azmitia, Efrain

PY - 1993/4/22

Y1 - 1993/4/22

N2 - The direct effects of 3,4-methylenedioxymethamphetamine (MDMA) and p-chloroamphetamine (PCA) were studied in microculture of fetal 5-hydroxytryptamine (5-HT) neurons. Both MDMA and PCA released 5-HT with the potency of PCA > MDMA by a mechanism inhibited by fluoxetine, an inhibitor of the 5-HT transporter. The transporter-mediated release by MDMA and PCA reduced intracellular stores of 5-HT. Both MDMA and PCA inhibit MAO-A activities, which also contributes to the increase of extracellular 5-HT levels. Deprenyl (10-7 M) increased the amount of intracellular 5-HT and potentiated the MDMA- or PCA-induced release of 5-HT. Conversely, reserpine (10-9 M) reduced the intracellular 5-HT level and attenuated the transporter-mediated release. In addition, MDMA- or PCA-mediated release was attenuated by nimodipine (10-8 M), an L-type Ca2+ channel antagonist. Our results indicate that MDMA- or PCA-induced release of 5-HT occurs from the cytoplasm to the media through the 5-HT transporter, and that the release may incorporate 5-HT from the vesicular stores.

AB - The direct effects of 3,4-methylenedioxymethamphetamine (MDMA) and p-chloroamphetamine (PCA) were studied in microculture of fetal 5-hydroxytryptamine (5-HT) neurons. Both MDMA and PCA released 5-HT with the potency of PCA > MDMA by a mechanism inhibited by fluoxetine, an inhibitor of the 5-HT transporter. The transporter-mediated release by MDMA and PCA reduced intracellular stores of 5-HT. Both MDMA and PCA inhibit MAO-A activities, which also contributes to the increase of extracellular 5-HT levels. Deprenyl (10-7 M) increased the amount of intracellular 5-HT and potentiated the MDMA- or PCA-induced release of 5-HT. Conversely, reserpine (10-9 M) reduced the intracellular 5-HT level and attenuated the transporter-mediated release. In addition, MDMA- or PCA-mediated release was attenuated by nimodipine (10-8 M), an L-type Ca2+ channel antagonist. Our results indicate that MDMA- or PCA-induced release of 5-HT occurs from the cytoplasm to the media through the 5-HT transporter, and that the release may incorporate 5-HT from the vesicular stores.

KW - Clorgyline

KW - Deprenyl

KW - Fluoxetine

KW - MDMA (3,4-methylenedioxymethamphetamine)

KW - Nimodipine

KW - Parachloroamphetamine

KW - Reserpine

UR - http://www.scopus.com/inward/record.url?scp=0027315361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027315361&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(93)90819-4

DO - 10.1016/0014-2999(93)90819-4

M3 - Article

C2 - 8100196

AN - SCOPUS:0027315361

VL - 235

SP - 51

EP - 57

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -